![](/img/cover-not-exists.png)
Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy
Nguyen, HuyTram N., Lie, Amy, Li, Tie, Chowdhury, Reshmi, Liu, Fei, Ozer, Byram, Wei, Bowen, Green, Richard M., Ellingson, Benjamin M., Wang, He-jing, Elashoff, Robert, Liau, Linda M., Yong, William HLanguage:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/now189
Date:
August, 2016
File:
PDF, 369 KB
english, 2016